At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
NRXP NRX Pharmaceuticals Inc.
Post-Market Trading 01-08 19:58:51 EST
3.76
-0.90
-19.31%
盘后3.92
+0.16+4.12%
19:57 EST
High4.79Low3.20Vol2.86M
Open4.78D1 Closing4.66Amplitude34.12%
Mkt Cap45.35MTradable Cap34.76MTotal Shares12.06M
T/O11.38MT/O Rate30.90%Tradable Shares9.24M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Dr. Jonathan Javitt and Dr. David Feifel to Present Keynote Address, Beyond Ketamine Monotherapy: Combined Interventional Treatment of Suicidal Depression and PTSD, at the 8th Annual Neuroscience Innovation Forum in San Francisco
PR Newswire  ·  01-07 21:07
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Dr. Jonathan Javitt and Dr. David Feifel to Present Keynote Address, Beyond Ketamine Monotherapy: Combined Interventional Treatment of Suicidal Depression and PTSD, at the 8th Annual Neuroscience Innovation Forum in San Francisco
NRx Pharmaceuticals' Acquisition Likely to Result in Multiple Avenues of Growth -- Market Talk
Dow Jones  ·  01-07 08:00
NRx Pharmaceuticals' Acquisition Likely to Result in Multiple Avenues of Growth -- Market Talk
BRIEF-Hope Therapeutics™, Inc. And Nrx Pharmaceuticals, Inc.Announce Signing Of Binding Term Sheet For $27 Million In Funding For Hope Clinic Acquisitions And Pharmaceutical Operations
Reuters  ·  01-07 01:07
BRIEF-Hope Therapeutics™, Inc. And Nrx Pharmaceuticals, Inc.Announce Signing Of Binding Term Sheet For $27 Million In Funding For Hope Clinic Acquisitions And Pharmaceutical Operations
NRx Pharmaceuticals, HOPE sign term sheet for $27M in funding
TIPRANKS  ·  01-06 23:20
NRx Pharmaceuticals, HOPE sign term sheet for $27M in funding
NRX Pharmaceuticals Inc: Smith & Sauer Will Be Entitled to Receive Royalties on Net REV From NRX Product Sales to a Defined Rate of Return
THOMSON REUTERS  ·  01-06 23:16
NRX Pharmaceuticals Inc: Smith & Sauer Will Be Entitled to Receive Royalties on Net REV From NRX Product Sales to a Defined Rate of Return
NRX Pharmaceuticals Inc: Smith & Sauer to Join Hope Therapeutics and Co's Boards
THOMSON REUTERS  ·  01-06 23:16
NRX Pharmaceuticals Inc: Smith & Sauer to Join Hope Therapeutics and Co's Boards
Hope Therapeutics™, Inc. and NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Announce Signing of Binding Term Sheet for $27 Million in Funding for Hope Clinic Acquisitions and Pharmaceutical Operations
THOMSON REUTERS  ·  01-06 23:16
Hope Therapeutics™, Inc. and NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Announce Signing of Binding Term Sheet for $27 Million in Funding for Hope Clinic Acquisitions and Pharmaceutical Operations
Press Release: HOPE Therapeutics(TM), Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of Binding Term Sheet for $27 Million in Funding for HOPE Clinic Acquisitions and Pharmaceutical Operations
Dow Jones  ·  01-06 23:16
Press Release: HOPE Therapeutics(TM), Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of Binding Term Sheet for $27 Million in Funding for HOPE Clinic Acquisitions and Pharmaceutical Operations
BRIEF-Hope Therapeutics, NRX Pharmaceuticals Announce Dura Medical As The Expected Initial Florida Acquisition
Reuters  ·  01-06 21:57
BRIEF-Hope Therapeutics, NRX Pharmaceuticals Announce Dura Medical As The Expected Initial Florida Acquisition
NRX Pharmaceuticals Inc: Acquisition Expected to Be Immediately Accretive to Revenue and Ebitda for NRX
THOMSON REUTERS  ·  01-06 21:03
NRX Pharmaceuticals Inc: Acquisition Expected to Be Immediately Accretive to Revenue and Ebitda for NRX
Hope Therapeutics, Inc. and NRX Pharmaceuticals, Inc. (Nasdaq: Nrxp) Announce Dura Medical as the Expected Initial Florida Acquisition for Its Planned International Network of Interventional Psychiatry Clinics
THOMSON REUTERS  ·  01-06 21:03
Hope Therapeutics, Inc. and NRX Pharmaceuticals, Inc. (Nasdaq: Nrxp) Announce Dura Medical as the Expected Initial Florida Acquisition for Its Planned International Network of Interventional Psychiatry Clinics
Press Release: HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Announce Dura Medical as the Expected Initial Florida Acquisition for its Planned International Network of Interventional Psychiatry Clinics
Dow Jones  ·  01-06 21:03
Press Release: HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Announce Dura Medical as the Expected Initial Florida Acquisition for its Planned International Network of Interventional Psychiatry Clinics
New Strong Buy Stocks for January 6th
Zacks  ·  01-06 17:16
New Strong Buy Stocks for January 6th
Hope Therapeutics, Inc., an NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Subsidiary, Will Host an Investor Workshop for Qualified Institutional Investors at the Mar-a-Lago Club During the Week of January 6, 2025
THOMSON REUTERS  ·  01-03
Hope Therapeutics, Inc., an NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Subsidiary, Will Host an Investor Workshop for Qualified Institutional Investors at the Mar-a-Lago Club During the Week of January 6, 2025
HOPE Therapeutics, Inc., an NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Subsidiary, Will Host an Investor Workshop for Qualified Institutional Investors at the Mar-A-Lago Club During the Week of January 6, 2025
PR Newswire  ·  01-03
HOPE Therapeutics, Inc., an NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Subsidiary, Will Host an Investor Workshop for Qualified Institutional Investors at the Mar-A-Lago Club During the Week of January 6, 2025
Sector Update: Health Care Stocks Softer Late Afternoon
MT Newswires Live  ·  01-03
Sector Update: Health Care Stocks Softer Late Afternoon
Sector Update: Health Care Stocks Ease Thursday Afternoon
MT Newswires Live  ·  01-03
Sector Update: Health Care Stocks Ease Thursday Afternoon
NRx Pharmaceuticals Stock Rises 33% on Psychiatry Clinic Acquisition
Dow Jones  ·  01-03
NRx Pharmaceuticals Stock Rises 33% on Psychiatry Clinic Acquisition
NRX Pharmaceuticals Unit to Acquire Kadima Neuropsychiatry Institute; Shares Rise
MT Newswires Live  ·  01-02
NRX Pharmaceuticals Unit to Acquire Kadima Neuropsychiatry Institute; Shares Rise
NRx Pharmaceuticals, Hope announce planned acquisition of Kadima
TIPRANKS  ·  01-02
NRx Pharmaceuticals, Hope announce planned acquisition of Kadima

Introduction

Company Name.
NRX Pharmaceuticals Inc.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. Its products include NRX-101 (D-cycloserine/Lurasidone), an oral, fixed dosed combination of D-cycloserine and lurasidone that earned food and drug administration-designated breakthrough therapy for suicidal treatment-resistant bipolar depression; and NRX-100 (ketamine), which has been awarded FDA fast track designation for the treatment of severe bipolar depression with acute suicidal ideation and behavior. The company has a partnership with Alvogen Inc. and Lotus Pharmaceutical Company; development and manufacturing agreement with Nephron Pharmaceuticals, Inc. and Alcami; license agreement with Apkarian Technologies; development and license agreement with Glytech; license agreement with Sarah Herzog Memorial Hospital. The company was founded in 2015 and is based in Wilmington, Delaware.
Issue price:
--